{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:44:36Z","timestamp":1791434676920,"version":"4.3.3"},"reference-count":188,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":4160,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s13311-012-0112-2","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T06:30:06Z","timestamp":1332484206000},"page":"270-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["Huntington's Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Michelle E.","family":"Ehrlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-012-0112-2_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1007\/s13311-012-0112-2_bib2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","article-title":"Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features","volume":"113","author":"Han","year":"2010","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-012-0112-2_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0595-104","article-title":"Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form","volume":"10","author":"Trottier","year":"1995","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-012-0112-2_bib5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0896-6273(01)00422-6","article-title":"Polyglutamine\u00acexpanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7","volume":"31","author":"La Spada","year":"2001","journal-title":"Neuron"},{"key":"10.1007\/s13311-012-0112-2_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0896-6273(02)01190-X","article-title":"SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity","volume":"37","author":"Yoo","year":"2003","journal-title":"Neuron"},{"key":"10.1007\/s13311-012-0112-2_bib7","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1073\/pnas.1018748108","article-title":"Regional rescue of spinocerebellar ataxia type 1 phenotypes by 14-3-3epsilon haploin sufficiency in mice underscores complex pathogenicity in neurodegeneration","volume":"108","author":"Jafar-Nejad","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function; interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1007\/s13311-012-0112-2_bib9","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1073\/pnas.1133382100","article-title":"Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2","volume":"100","author":"Marcora","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nn1702","article-title":"Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function","volume":"9","author":"Yanai","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1172871","article-title":"Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity","volume":"324","author":"Subramaniam","year":"2009","journal-title":"Science"},{"key":"10.1007\/s13311-012-0112-2_bib12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.neuropharm.2010.10.025","article-title":"Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum)","volume":"60","author":"Subramaniam","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-012-0112-2_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1007\/s13311-012-0112-2_bib14","article-title":"Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases","author":"Sambataro","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-012-0112-2_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1007\/s13311-012-0112-2_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","article-title":"Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease","volume":"2","author":"Gu","year":"2007","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-012-0112-2_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1007\/s13311-012-0112-2_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-8993(98)00724-0","article-title":"Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen","volume":"808","author":"Ouimet","year":"1998","journal-title":"Brain Res"},{"key":"10.1007\/s13311-012-0112-2_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-012-0112-2_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001756-200303240-00007","article-title":"Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation","volume":"14","author":"Igarashi","year":"2003","journal-title":"Neuroreport"},{"key":"10.1007\/s13311-012-0112-2_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/exnr.2000.7551","article-title":"ST14A cells have properties of a medium-size spiny neuron","volume":"167","author":"Ehrlich","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"Sipione","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib23","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib24","article-title":"Viral-mediated overexpression of mutant huntingtin to model HD in various species","author":"Ruiz","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib25","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1093\/hmg\/ddn206","article-title":"Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse","volume":"17","author":"Brown","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib26","unstructured":"Cantle JP, Wang N, Gray M, et al. Genetic and molecular analyses of non-cell-autonomous disease pathogenesis in a conditional BAC transgenic mouse model of Huntington's disease (BACHD). SFN Annual Meeting 2011:148.21."},{"key":"10.1007\/s13311-012-0112-2_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet"},{"key":"10.1007\/s13311-012-0112-2_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1471-4159.2005.03588.x","article-title":"Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease","volume":"96","author":"Desplats","year":"2006","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-012-0112-2_bib29","first-page":"111","article-title":"DARPP-32, a dopamine- and adenosine 3\u2018: 5\u2018-monophosphate- regulated phosphoprotein enriched in dopamine-innervated brain regions","volume":"4","author":"Ouimet","year":"1984","journal-title":"III. Immunocytochemical localization. J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib30","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib31","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","article-title":"Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice","volume":"22","author":"Menalled","year":"2002","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib32","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","article-title":"Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neuroscience.2004.10.037","article-title":"Neuronal intranuclear inclusions and neuropil aggregates in HdhCAG(150) knockin mice","volume":"131","author":"Tallaksen-Greene","year":"2005","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-012-0112-2_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1007\/s13311-012-0112-2_bib35","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","article-title":"Enhanced Akt signaling is an early pro-survival response that reflects N-Methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells","volume":"278","author":"Gines","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0112-2_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib37","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1523\/JNEUROSCI.4619-08.2008","article-title":"Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity","volume":"28","author":"Cowan","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib38","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglytamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib39","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/hmg\/ddg305","article-title":"Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum","volume":"12","author":"Regulier","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib40","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nbd.2005.05.017","article-title":"Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment","volume":"20","author":"Zala","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/gene.20118","article-title":"DARPP-32 genomic fragments drive Cre expression in postnatal striatum","volume":"42","author":"Bogush","year":"2005","journal-title":"Genesis"},{"key":"10.1007\/s13311-012-0112-2_bib44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddq548","article-title":"In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons","volume":"20","author":"Thomas","year":"2011","journal-title":"Hum Mol Genetics"},{"key":"10.1007\/s13311-012-0112-2_bib45","doi-asserted-by":"crossref","first-page":"e00060","DOI":"10.1042\/AN20110009","article-title":"Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function","volume":"3","author":"Kim","year":"2011","journal-title":"ASN Neuro"},{"key":"10.1007\/s13311-012-0112-2_bib46","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1093\/hmg\/ddr355","article-title":"Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative","volume":"20","author":"Fossale","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0297-197","article-title":"Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation","volume":"15","author":"Mangiarini","year":"1997","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-012-0112-2_bib48","first-page":"e1000749","article-title":"Wheeler VC, Trottier Y","volume":"5","author":"Goula","year":"2009","journal-title":"Merienne K. Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS Genet"},{"key":"10.1007\/s13311-012-0112-2_bib49","first-page":"e23647","article-title":"St Claire JC","volume":"6","author":"Lee","year":"2011","journal-title":"Wheeler VC. Quantification of age-dependent somatic CAG repeat instability in Hdh CAG knock-in mice reveals different expansion dynamics in striatum and liver. PLoS One"},{"key":"10.1007\/s13311-012-0112-2_bib50","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/ddg300","article-title":"Regional differences of somatic CAG repeat instability do not account for selective neuronal vulnerability in a knock-in mouse model of SCA1","volume":"12","author":"Watase","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0305-1846.2001.00299.x","article-title":"The selective vulnerability of nerve cells in Huntington's disease","volume":"27","author":"Sieradzan","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1007\/s13311-012-0112-2_bib52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1007\/s13311-012-0112-2_bib53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(94)90132-5","article-title":"Huntington's disease, energy, and excitotoxicity","volume":"15","author":"Beal","year":"1994","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-012-0112-2_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease","volume":"58","author":"Levine","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-012-0112-2_bib55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1749-6632.1999.tb07827.x","article-title":"Bioenergetics in Huntington's disease","volume":"893","author":"Grunewald","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1007\/s13311-012-0112-2_bib56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/NMM:3:2:65","article-title":"Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders","volume":"3","author":"Mattson","year":"2003","journal-title":"Neuromolecular Med"},{"key":"10.1007\/s13311-012-0112-2_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","article-title":"Selective neuronal degeneration in Huntington's disease","volume":"75","author":"Cowan","year":"2006","journal-title":"Curr Top Dev Biol"},{"key":"10.1007\/s13311-012-0112-2_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib59","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1046\/j.1471-4159.2003.01916.x","article-title":"Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6\/2 transgenic mice","volume":"86","author":"Gourfinkel-An","year":"2003","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-012-0112-2_bib60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1007\/s13311-012-0112-2_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1007\/s13311-012-0112-2_bib62","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib63","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib64","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivoin vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1007\/s13311-012-0112-2_bib65","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1093\/hmg\/ddq361","article-title":"A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons","volume":"19","author":"Braunstein","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Li\u00e9vens","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib67","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib68","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice","volume":"285","author":"Bradford","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0112-2_bib69","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1 alpha contributes to dysmyelination in experimental models of Huntington's disease","volume":"31","author":"Xiang","year":"2011","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib70","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib71","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"10.1007\/s13311-012-0112-2_bib72","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum Brain Mapp"},{"key":"10.1007\/s13311-012-0112-2_bib73","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neurobiolaging.2011.02.015","article-title":"Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons","volume":"33","author":"Kraft","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-012-0112-2_bib74","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1046\/j.0953-816x.2001.01783.x","article-title":"Differential sensitivity of medium- and large-sized striatal neurons to NMDA but not kainate receptor activation in the rat","volume":"14","author":"Cepeda","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2005.08.062","article-title":"Hyperactive striatal neurons in symptomatic Huntington R6\/2 mice: variations with behavioral state and repeated ascorbate treatment","volume":"137","author":"Rebec","year":"2006","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-012-0112-2_bib76","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","article-title":"Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease","volume":"29","author":"Graham","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib77","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jnr.20492","article-title":"Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes","volume":"80","author":"Ariano","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-012-0112-2_bib78","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2005.08.062","article-title":"Hyperactive striatal neurons in symptomatic Huntington R6\/2 mice: variations with behavioral state and repeated ascorbate treatment","volume":"137","author":"Rebec","year":"2006","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-012-0112-2_bib79","doi-asserted-by":"crossref","first-page":"e00033","DOI":"10.1042\/AN20090058","article-title":"Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms","volume":"2","author":"Cepeda","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1007\/s13311-012-0112-2_bib80","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1007\/s13311-012-0112-2_bib81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/hmg\/8.1.25","article-title":"In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease","volume":"8","author":"Hackam","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib82","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1007\/s13311-012-0112-2_bib83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2008.10.008","article-title":"Implication of the JNK pathway in a rat model of Huntington's disease","volume":"215","author":"Perrin","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib84","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1007\/s13311-012-0112-2_bib85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib86","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/hmg\/ddr023","article-title":"Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation","volume":"20","author":"Havel","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib87","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice","volume":"64","author":"Gu","year":"2009","journal-title":"Neuron"},{"key":"10.1007\/s13311-012-0112-2_bib88","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1523\/JNEUROSCI.1589-10.2010","article-title":"Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A","volume":"30","author":"Metzler","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib89","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1126\/science.281.5378.838","article-title":"DARPP-32:regulator of the efficacy of dopaminergic neurotransmission","volume":"281","author":"Fienberg","year":"1998","journal-title":"Science"},{"key":"10.1007\/s13311-012-0112-2_bib90","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-012-0112-2_bib91","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1007\/s13311-012-0112-2_bib92","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"10.1007\/s13311-012-0112-2_bib93","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","article-title":"Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin","volume":"23","author":"Jiang","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib94","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1007\/s13311-012-0112-2_bib95","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","article-title":"Mechanisms of disease: Histone modifications in Huntington's disease","volume":"2","author":"Sadri-Vakili","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib96","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib97","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib98","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/NEN.0b013e3181ed7a41","article-title":"Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease","volume":"69","author":"Zucker","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib99","doi-asserted-by":"crossref","first-page":"44889","DOI":"10.1074\/jbc.M106575200","article-title":"The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease","volume":"276","author":"Chai","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0112-2_bib100","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1007\/s13311-012-0112-2_bib101","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1007\/s13311-012-0112-2_bib102","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib103","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.nbd.2008.05.005","article-title":"Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease","volume":"31","author":"Desplats","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib104","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1046\/j.1471-4159.2001.00651.x","article-title":"Role of phosphatidylinositide 3-kinase in brain-derived neurotrophic factor-induced DARPP-32 expression in medium size spiny neurons in vitro","volume":"79","author":"Stroppolo","year":"2001","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-012-0112-2_bib105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/scdb.1998.0281","article-title":"GATA transcription factors and cardiac development","volume":"10","author":"Charron","year":"1999","journal-title":"Semin Cell Dev Biol"},{"key":"10.1007\/s13311-012-0112-2_bib106","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1523\/JNEUROSCI.3044-08.2008","article-title":"Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry","volume":"28","author":"Runne","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0306-4522(96)00684-7","article-title":"Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium size spiny neurons: Studies in vivoin vitro","volume":"79","author":"Ivkovic","year":"1997","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-012-0112-2_bib108","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1523\/JNEUROSCI.19-13-05409.1999","article-title":"Expression of the striatal DARPP-32\/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivoin vitro","volume":"19","author":"Ivkovic","year":"1999","journal-title":"J Neuroscience"},{"key":"10.1007\/s13311-012-0112-2_bib109","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"Spec No. 2","key":"10.1007\/s13311-012-0112-2_bib110","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","article-title":"Polyglutamine diseases: emerging concepts in pathogenesis and therapy","volume":"16","author":"Shao","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib111","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"6","author":"Kuhn","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib112","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib113","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib114","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1523\/JNEUROSCI.22-18-08158.2002","article-title":"Synaptic convergence of motor and somatosensory cortical afferents onto GABAergic interneurons in the rat striatum","volume":"22","author":"Ramanathan","year":"2002","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0165-0173(00)00039-4","article-title":"Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease","volume":"34","author":"Cicchetti","year":"2000","journal-title":"Brain Res Rev"},{"key":"10.1007\/s13311-012-0112-2_bib116","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1523\/JNEUROSCI.0698-10.2010","article-title":"Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha","volume":"30","author":"Lucas","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib117","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399409001094","article-title":"The Nrf2-ARE cytoprotective pathway in astrocytes","volume":"11","author":"Vargas","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"10.1007\/s13311-012-0112-2_bib118","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-012-0112-2_bib119","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","article-title":"CRE-mediated transcription is increased in Huntington's disease transgenic mice","volume":"28","author":"Obrietan","year":"2004","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib120","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1074\/jbc.M511648200","article-title":"Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective","volume":"281","author":"Qiu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0112-2_bib121","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nrn1989","article-title":"Histone deacetylase inhibitors as therapeutics for polyglutamine disorders","volume":"7","author":"Butler","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib122","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-291X(03)00115-3","article-title":"Histone H3 is aberrantly phosphorylated in glutamine-repeat diseases","volume":"302","author":"Yazawa","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-012-0112-2_bib123","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","article-title":"Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease","volume":"22","author":"Chen-Plotkin","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib124","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0112-2_bib126","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib127","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.mcn.2005.12.004","article-title":"Brain-specific factors in combination with mutant huntingtin induce gene-specific transcriptional dysregulation","volume":"31","author":"Gomez","year":"2006","journal-title":"Mol Cell Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib129","first-page":"F564","article-title":"DARPP-32 promoter directs transgene expression to renal thick ascending limb of loop of Henle","volume":"269","author":"Blau","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1007\/s13311-012-0112-2_bib130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-012-0112-2_bib131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1007\/s13311-012-0112-2_bib132","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"issue":"pt 6","key":"10.1007\/s13311-012-0112-2_bib133","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/brain\/110.6.1657","article-title":"Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease","volume":"110","author":"Ellison","year":"1987","journal-title":"Brain"},{"key":"10.1007\/s13311-012-0112-2_bib134","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington's disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib136","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib137","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/WNL.24.9.813","article-title":"Biochemical abnormalities in Huntington's chorea brains","volume":"24","author":"Stahl","year":"1974","journal-title":"Neurology"},{"key":"10.1007\/s13311-012-0112-2_bib138","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington's disease brain","volume":"44","author":"Brennan","year":"1985","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-012-0112-2_bib139","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat Med"},{"key":"10.1007\/s13311-012-0112-2_bib140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse","volume":"47","author":"Tabrizi","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib141","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib142","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1007\/s13311-012-0112-2_bib143","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib144","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1212\/WNL.40.8.1231","article-title":"Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease","volume":"40","author":"Parker","year":"1990","journal-title":"Neurology"},{"key":"10.1007\/s13311-012-0112-2_bib145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410430321","article-title":"Complex I defect in muscle from patients with Huntington's disease","volume":"43","author":"Arenas","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-012-0112-2_bib146","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib147","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/hmg\/ddn033","article-title":"Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II","volume":"17","author":"Benchoua","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-012-0112-2_bib148","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.bbabio.2009.03.010","article-title":"Mitochondrial calcium function and dysfunction in the central nervous system","volume":"1787","author":"Nicholls","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-012-0112-2_bib149","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib151","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","article-title":"In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"29","author":"Heng","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib152","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat Med"},{"key":"10.1007\/s13311-012-0112-2_bib153","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1007\/s13311-012-0112-2_bib154","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.mp.4002017","article-title":"Excitotoxicity and focal cerebral ischemia induce truncation of the NR2A and NR2B subunits of the NMDA receptor and cleavage of the scaffolding protein PSD-95","volume":"13","author":"Gasc\u00f3n","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-012-0112-2_bib155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-8993(91)90631-5","article-title":"Effects of aging on quinolinic acid lesions in rat striatum","volume":"562","author":"Finn","year":"1991","journal-title":"Brain Res"},{"key":"10.1007\/s13311-012-0112-2_bib156","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0306-4522(96)00056-5","article-title":"Aging reduces neostriatal responsiveness to N-methyl-D-aspartate and dopamine: an in vitro electrophysiological study","volume":"73","author":"Cepeda","year":"1996","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-012-0112-2_bib157","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-012-0112-2_bib158","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/biof.162","article-title":"Huntington's disease, calcium, and mitochondria","volume":"37","author":"Giacomello","year":"2011","journal-title":"Biofactors"},{"key":"10.1007\/s13311-012-0112-2_bib159","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib160","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib161","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0371147","article-title":"Coupling of the NMDA receptor to neuroprotective and neurodestructive events","volume":"37","author":"Hardingham","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1007\/s13311-012-0112-2_bib162","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2174\/156802606777057562","article-title":"The NMDA\/D1 receptor complex as a new target in drug development","volume":"6","author":"Missale","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1007\/s13311-012-0112-2_bib163","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuropharm.2010.01.008","article-title":"Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum","volume":"58","author":"Lovinger","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-012-0112-2_bib164","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington's disease","volume":"227","author":"Tang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib165","doi-asserted-by":"crossref","first-page":"e8287","DOI":"10.1371\/journal.pone.0008287","article-title":"Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho\/ROCK-II activation","volume":"4","author":"Deyts","year":"2009","journal-title":"PLoS One"},{"key":"10.1007\/s13311-012-0112-2_bib166","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1046\/j.1460-9568.1998.00357.x","article-title":"Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons","volume":"10","author":"Cepeda","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib167","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.mcn.2011.05.001","article-title":"Mechanisms underlying NMDA receptor synaptic\/extrasynaptic distribution and function","volume":"48","author":"Gladding","year":"2011","journal-title":"Mol Cell Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib168","doi-asserted-by":"crossref","first-page":"15799","DOI":"10.1074\/jbc.M801553200","article-title":"Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons","volume":"283","author":"Iwakura","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0112-2_bib169","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1007\/s13311-012-0112-2_bib170","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1523\/JNEUROSCI.17-07-02295.1997","article-title":"Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport","volume":"17","author":"Conner","year":"1997","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib171","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1523\/JNEUROSCI.18-15-06040.1998","article-title":"Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenic appearance of BDNF in the striatum","volume":"18","author":"Yurek","year":"1998","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib172","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","article-title":"Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain","volume":"18","author":"Fusco","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib173","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","article-title":"Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease","volume":"11","author":"Hermel","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1007\/s13311-012-0112-2_bib174","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain","volume":"23","author":"Gines","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1007\/s13311-012-0112-2_bib176","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib177","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1523\/JNEUROSCI.5100-09.2010","article-title":"Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth","volume":"30","author":"Rauskolb","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib178","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1074\/jbc.M606508200","article-title":"AKT and CDK5\/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro","volume":"282","author":"Bogush","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-012-0112-2_bib179","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-012-0112-2_bib180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(98)00287-5","article-title":"Compartmental expression of trkB receptor protein in the developing striatum","volume":"89","author":"Costantini","year":"1999","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-012-0112-2_bib181","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1126\/science.7725105","article-title":"Potentiated necrosis of cultured cortical neurons by neurotrophins","volume":"268","author":"Koh","year":"1995","journal-title":"Science"},{"key":"10.1007\/s13311-012-0112-2_bib182","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2000.740582.x","article-title":"Brain-derived neurotrophic factor induces excitotoxic sensitivity in cultures embryonic rat spinal motor neurons through activation of the phosphatidylinositol 3-kinase pathway","volume":"74","author":"Fryer","year":"2000","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-012-0112-2_bib183","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1046\/j.1471-4159.2003.01599.x","article-title":"BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB","volume":"84","author":"Hu","year":"2003","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-012-0112-2_bib184","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.1523\/JNEUROSCI.1856-06.2006","article-title":"Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors","volume":"26","author":"Mojsilovic-Petrovic","year":"2006","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-012-0112-2_bib185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","article-title":"Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH58261 in R6\/2 Huntington's disease mice","volume":"28","author":"Domenici","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib186","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-012-0112-2_bib187","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nbd.2007.10.003","article-title":"Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling","volume":"29","author":"Torres-Peraza","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-012-0112-2_bib188","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.08.012","article-title":"Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity","volume":"36","author":"Xifr\u00f3","year":"2009","journal-title":"Neurobiol Dis"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-012-0112-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-012-0112-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923017440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923017440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-012-0112-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:09:15Z","timestamp":1761808155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923017440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":188,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1878747923017440"],"URL":"https:\/\/doi.org\/10.1007\/s13311-012-0112-2","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huntington's Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-012-0112-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}